Postdoc at Stanford in Mike Snyder's Lab in the Department of Genetics. Ariel's research focuses on Mental Health and Precision Medicine. She is the co-founding partner of Arben Ventures, a seed stage, Stanford Adjacent Precision Medicine Fund investing in the Stanford Healthcare Innovation Lab Ecosystem.